About IntegenX
IntegenX is a company based in Pleasanton (United States) founded in 2006 was acquired by Thermo Fisher Scientific in March 2018. IntegenX has raised $92.06 million across 9 funding rounds from investors including Thermo Fisher Scientific, Square 1 Bank and HHS. The company has 78 employees as of December 31, 2017. IntegenX has completed 1 acquisition, including GenVault Corporation. IntegenX offers products and services including RapidHIT ID System and TaqMan Real-Time PCR Assays. IntegenX operates in a competitive market with competitors including DDC Paternity Tests, Othram, ANDE, Applied DNA Sciences and Ameritox, among others.
- Headquarter Pleasanton, United States
- Employees 78 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Thermo Fisher Scientific Inc.
-
Annual Revenue
$22.5 B (USD)14513as on Dec 31, 2024
-
Net Profit
$6.34 B (USD)6as on Dec 31, 2024
-
EBITDA
$1.96 B (USD)2as on Dec 31, 2024
-
Total Equity Funding
$92.06 M (USD)
in 9 rounds
-
Latest Funding Round
$10 M (USD), Debt – Venture
Sep 22, 2014
-
Investors
Thermo Fisher Scientific
& 12 more
-
Employee Count
78
as on Dec 31, 2017
- Investments & Acquisitions
-
Acquired by
Thermo Fisher Scientific
(Mar 16, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntegenX
IntegenX offers a comprehensive portfolio of products and services, including RapidHIT ID System and TaqMan Real-Time PCR Assays.
Compact system for generating DNA profiles in forensic settings
Assays for DNA analysis in various scientific applications
Funding Insights of IntegenX
IntegenX has successfully raised a total of $92.06M across 9 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $10 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IntegenX
IntegenX has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Square 1 Bank and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured debt is provided to life sciences and technology firms.
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
Expansion stage tech-focused VC firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for IntegenX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IntegenX
IntegenX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GenVault Corporation.
Investment portfolio details for IntegenX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for IntegenX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - IntegenX
Detailed financials for IntegenX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Integenx Comparisons
Peer comparison for IntegenX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IntegenX
IntegenX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DDC Paternity Tests, Othram, ANDE, Applied DNA Sciences and Ameritox, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA tests and personalized diagnostics are provided for various specialties.
|
|
| Locked | Locked | Locked |
Genomic services are provided for forensic investigations and research.
|
|
| Locked | Locked | Locked |
Rapid DNA systems are provided for forensic identification and diagnostics.
|
|
| Locked | Locked | Locked |
Botanical-DNA-based security and authentication solutions are developed.
|
|
| Locked | Locked | Locked |
Pain medication monitoring solutions are provided for US clinicians.
|
Detailed competitors of IntegenX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Integenx
Complete news archive for IntegenX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntegenX
IntegenX was founded in 2006.
IntegenX is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
IntegenX is a funded company, having raised a total of $92.06M across 9 funding rounds to date.
As of Dec 31, 2017, the latest employee count at IntegenX is 78.
Annual revenue of IntegenX is $22.5B as on Dec 31, 2024.
Founded in 2006 and based in Pleasanton, United States, IntegenX operates in the forensics and law enforcement sector. Advanced fluidics, optics, and biochemistry are integrated into its proprietary platforms to create sample-to-answer products for DNA-based identity testing. As of January 2016, the RapidHIT ID and RapidHIT System, along with supporting reagent kits, are offered for these applications.
IntegenX's top competitors include DDC Paternity Tests, Key Forensic Services and Applied DNA Sciences.
IntegenX offers RapidHIT ID System and TaqMan Real-Time PCR Assays.
IntegenX has made 1 acquisition, including GenVault Corporation.
IntegenX has 13 investors. Key investors include Thermo Fisher Scientific, Square 1 Bank, HHS, Horizon Tech Finance, and Western Technology Investment.